30 June 2001

Contents

Conference reports

• 4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy, April 19-21, 2001, Cannes, France

• 4th International Conference on Nutrition and HIV Infection and the 2nd European Workshop on Lipodystrophy – pt 2

• Keystone Symposium on HIV, March 28-April 3, Keystone, Colorado: more than one way to skin a virus: innate immune factors that suppress HIV replication

Antiretrovirals

• Tenofovir: Gilead applies for approval, expanded access relaxed

Treatment access

• Cipla announces plan to manufacture 3-in-1 HIV pil

• Huge mining firm to provide African employees with AIDS medications

• South African Department of health has not killed possibility of AIDS drug provision, letter says

• Government, pricing not the only problems

• South Africa AIDS drug settlement may not signify immediate influx of drugs

• AIDS crisis has Sspurred public relations challenges for pharmaceutical industry, Wall Street Journal reports

Women's health

• A new women’s research agenda starts to see the light of day

• Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART

Paediatric care

• Protease inhibitor therapy improves growth parameters of HIV-infected children

Coinfections and complications

• CD4+ counts predictive of musculoskeletal manifestations of HIV infection

• Effect of highly active antiretroviral therapy on frequency of oral warts

Drug resistance

• HIV drug resistance is increasing in the UK

Other news

• The relationships between ethnicity, sex, risk group,and virus load in HIV-1 antiretroviral-naive patients

• FDA warning to manufacturers of antiretrovirals over misleading advertising

• Mbeki questions validity of HIV testing

• Aerobic exercise benefits HIV-positive adults

• Whey proteins help replenish glutathione levels

• Therapeutic drug monitoring: ready For clinical practice?

• Expert column: recent developments and current issues in HIV-related renal disease

• HPV-induced anal dysplasia: what do We know and what can we do about it?